The global Salmonella Testing Market is estimated to be valued at US$2.91 billion in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
The Salmonella Testing Market is witnessing significant growth due to the increasing prevalence of salmonella infections worldwide. Salmonella is a leading cause of foodborne illnesses, causing symptoms such as diarrhea, fever, and abdominal cramps. The growing awareness about food safety and the stringent regulatory guidelines for food testing are major factors driving the market growth. However, high testing costs and lack of awareness about the importance of salmonella testing in certain regions are hindering the market growth.
Market Key Trends:
One key trend in the Salmonella Testing Market is the increasing adoption of rapid diagnostic tests. These tests provide quick and accurate results, enabling early detection of salmonella infections. For example, bioMérieux SA has developed VIDAS® UP Salmonella, a highly sensitive test that delivers results in just 24 hours. This rapid testing technology is revolutionizing the market by reducing turnaround time and improving patient care.
The Salmonella Testing Market is segmented based on the type of test, including culture-based tests, immunoassays, molecular diagnostic tests, and other tests. Among these, the immunoassay segment is dominating the market. Immunoassays are widely used for salmonella testing due to their simplicity, speed, and cost-effectiveness. These tests detect salmonella-specific antigens or antibodies in patient samples. The immunoassay segment is expected to witness significant growth owing to the increasing demand for rapid diagnostic tests.
The Global Salmonella Testing Market Demand is expected to witness high growth, exhibiting a CAGR of 7.8% over the forecast period. This growth is driven by factors such as increasing prevalence of salmonella infections, growing awareness about food safety, and stringent regulatory guidelines. The market is expected to be dominated by the immunoassay segment, which offers simplicity, speed, and cost-effectiveness in salmonella testing.
In terms of regional analysis, North America is the fastest-growing and dominating region in the Salmonella Testing Market. The region has a well-established healthcare infrastructure, stringent regulations governing food safety, and a high awareness about the importance of salmonella testing. The presence of key players such as Thermo Fisher Scientific and LabCorp further boosts the market growth in this region.
Key players operating in the global Salmonella Testing Market include Thermo Fisher Scientific, Merck KGaA, bioMérieux SA, Neogen Corporation, QIAGEN N.V., 3M Company, PerkinElmer Inc., Romer Labs Division Holding GmbH, Eurofins Scientific, Hardy Diagnostics, Charles River Laboratories International Inc., LabCorp, R-Biopharm AG, Biomerica Inc., and Zeulab S.L. These players are focusing on strategic collaborations, product launches, and acquisitions to expand their market presence and offer innovative solutions for salmonella testing.
In conclusion, the global Salmonella Testing Market is experiencing significant growth due to the increasing prevalence of salmonella infections and growing awareness about food safety. Rapid diagnostic tests and the immunoassay segment are emerging as key trends in the market. North America is the fastest-growing region, dominated by key players such as Thermo Fisher Scientific and LabCorp. With ongoing advancements in testing technologies and increased emphasis on food safety, the market is expected to witness continued growth in the forecast period.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it